| 1 |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.
|
| 2 |
Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries[J]. Lancet, 2018, 391(10125): 1023-1075.
|
| 3 |
National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening[J]. N Engl J Med, 2011, 365(5): 395-409.
|
| 4 |
中华医学会呼吸病学分会,中国肺癌防治联盟专家组. 肺结节诊治中国专家共识(2024年版)[J]. 中华结核和呼吸杂志,2024, 47(8): 716-729.
|
| 5 |
Tanner NT, Aggarwal J, Gould MK, et al. Management of pulmonary nodules by community pulmonologists: a multicenter observational study[J]. Chest, 2015, 148(6): 1405-1414.
|
| 6 |
Anderson IJ, Davis AM. Incidental pulmonary nodules detected on CT images[J]. JAMA, 2018, 320(21): 2260-2261.
|
| 7 |
Deppen SA, Blume JD, Kensinger CD, et al. Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis[J]. JAMA, 2014, 312(12): 1227-1236.
|
| 8 |
Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis[J]. JAMA, 2001, 285(7): 914-924.
|
| 9 |
Kastner J, Hossain R, Jeudy J, et al. Lung-RADS Version 1.0 versus lung-RADS version 1.1: comparison of categories using nodules from the national lung screening trial[J]. Radiology, 2021, 300(1): 199-206.
|
| 10 |
Gould MK, Ananth L, Barnett PG, et al. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules[J]. Chest, 2007, 131(2): 383-388.
|
| 11 |
Bai C, Choi CM, Chu CM, et al. Evaluation of pulmonary nodules: clinical practice consensus guidelines for Asia[J]. Chest, 2016, 150(4): 877-893.
|
| 12 |
MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the fleischner society 2017[J]. Radiology, 2017, 284(1): 228-243.
|
| 13 |
Evangelista L, Cuocolo A, Pace L, et al. Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial[J]. Eur J Nucl Med Mol Imaging, 2018, 45(11): 1898-1907.
|
| 14 |
Chen S, Harmon S, Perk T, et al. Using neighborhood gray tone difference matrix texture features on dual time point PET/CT images to differentiate malignant from benign FDG-avid solitary pulmonary nodules[J]. Cancer Imaging, 2019, 19(1): 56.
|
| 15 |
Chun EJ, Lee HJ, Kang WJ, et al. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT[J]. Lung Cancer, 2009, 65(2): 180-186.
|
| 16 |
Yang DW, Zhang Y, Hong QY, et al. Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients[J]. Cancer, 2015, 121(Suppl 17): 3113-3121.
|
| 17 |
Li Z, Wu W, Pan X, et al. Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinoma[J]. Cancer Med, 2022, 11(14): 2855-2864.
|
| 18 |
Wang H, Zhang J, Li X, et al. The utilization pattern of serum tumor markers in lung cancer patients: A population-based retrospective descriptive study[J]. J Clin Lab Anal, 2020, 34(11): e23465.
|
| 19 |
Pastor A, Menéndez R, Cremades MJ, et al. Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis[J]. Eur Respir J, 1997, 10(3): 603-609.
|
| 20 |
Song WA, Liu X, Tian XD, et al. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China[J]. Chin Med J (Engl), 2011, 124(20): 3244-3248.
|
| 21 |
Holt RIG, Cockram CS, Ma RCW, et al. Diabetes and infection: review of the epidemiology, mechanisms and principles of treatment[J]. Diabetologia, 2024, 67(7): 1168-1180.
|
| 22 |
Luk AOY, Wu H, Lau ESH, et al. Temporal trends in rates of infection-related hospitalisations in Hong Kong people with and without diabetes, 2001-2016: a retrospective study[J]. Diabetologia, 2021, 64(1): 109-118.
|